Senior Manager, GMP Quality
$158k/y-$198k/y
Revolution Medicines2 days ago
Highlight
OnsiteFull-timeSenior
Summary
Revolution Medicines is seeking a Senior Manager, GMP Quality to join their team in the San Francisco Bay Area. The role involves providing leadership and operational support for RevMed programs with a strong emphasis on Quality Control aspects associated with clinical and commercial products.
About the Role
As a Senior Manager, GMP Quality, you will be responsible for QA oversight of all Quality Control activities, collaborating with internal and external stakeholders on deviation investigations, and leading efforts for QA oversight of the manufacture and disposition of pre-clinical, clinical, and commercial product materials. You will also establish and maintain internal quality metrics, participate in inspection readiness efforts, and build positive professional relationships to support collaboration and teamwork.
About You
Required:
- A bachelor’s degree in a scientific or technical discipline.
- A minimum of 8 years of experience in GMP Quality in the pharmaceutical industry.
- Experience managing quality aspects of development, validation, manufacturing, and testing activities at CMOs.
- Experience in process validation (PPQ), late-stage regulatory submissions, and commercial readiness.
- Excellent analytical skills and a strong technical background in small molecule process development, validation, and testing.
- Knowledge of applicable US and Global compliance regulations and industry practices.
- Strong teamwork, collaboration, and management skills.
Preferred:
- Hands-on experience working in a manufacturing environment overseeing QA responsibilities for commercial and late-stage programs.
Benefits
- Competitive cash compensation.
- Robust equity awards.
- Strong benefits package including medical, dental, and vision coverage.
- Significant learning and development opportunities.
Revolution Medicines
We are Revolutionaries – passionate in our singular pursuit of discovering, developing and delivering innovative, targeted medicines for patients living with cancer. To deliver on our vision, we work relentlessly in pursuit of cutting-edge therapeutic approaches to some of the toughest cancers. Our current focus is on RAS-addicted cancers, which account for 30 percent of all new human cancer diagnoses.
San Francisco Bay Area